Search results
Vertex Energy, Inc. (NASDAQ:VTNR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 8 hours agoVertex Energy, Inc. (NASDAQ:VTNR) Q1 2024 Earnings Call Transcript May 9, 2024 Vertex Energy, Inc....
Vertex shares target raised by RBC on robust CF sales By Investing.com
Investing.com· 4 days agoOn Tuesday, RBC (TSX:RY) Capital Markets adjusted its price target for Vertex Pharmaceuticals...
Vertex Energy First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 16 hours agoVertex Energy (NASDAQ:VTNR) First Quarter 2024 Results Key Financial Results Revenue: US$695.3m...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo Finance· 4 days agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
WHTC 1450 Holland· 4 days ago(Reuters) - Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday,...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
GuruFocus.com via Yahoo Finance· 12 hours agoThe details were released through an 8-K filing. This announcement comes in the wake of a...
Vertex Resource Group Ltd.'s (CVE:VTX) CEO Compensation Looks Acceptable To Us And Here's Why
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Vertex Resource Group to hold its Annual General Meeting on 15th of May Total pay for...
Vertex Energy Inc (VTNR) Q1 2024 Earnings Overview: Mixed Results Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 9 hours agoStrategic Shift: Announced a pause in renewable fuels production, pivoting to conventional fuels to enhance financial performance. On May 9, 2024, Vertex Energy Inc (NASDAQ ...
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Investor's Business Daily· 3 days agoVertex stock advanced Tuesday as analysts debated the company's pain drug, VX-548, with one saying...